J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 78 (1997), 611-618
© 1997 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willett, B.
Right arrow Articles by Neil, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willett, B.
Right arrow Articles by Neil, J.
Agricola
Right arrow Articles by Willett, B.
Right arrow Articles by Neil, J.

Journal of General Virology, Vol 78, 611-618, Copyright © 1997 by Society for General Microbiology


ARTICLES

Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism

B Willett, M Hosie, A Shaw and J Neil
Department of Veterinary Pathology, University of Glasgow, UK. b.willett@vet.gla.ac.uk

A monoclonal antibody which blocks infection with feline immunodeficiency virus (FIV) was found previously to react with the cell surface molecule CD9, implicating CD9 in the process of virus entry. We report here that inhibition by anti-CD9 antibody does not operate at the level of virus entry but at a subsequent stage in the virus life-cycle. Moreover, inhibition of infection is independent of the passage history of the virus or the virus subtype. Inhibition of FIV infection by anti-CD9 antibody does not operate in 3201 cells, which do not express this surface antigen. However, ectopic expression of CD9 on 3201 cells enhances infection with FIV, suggesting that the role of CD9 may be direct rather than via cellular signalling pathways. These results suggest a novel control point in the lentivirus life- cycle which might be susceptible to modulation by natural antagonists.


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
O. V. Kovalenko, X. H. Yang, and M. E. Hemler
A Novel Cysteine Cross-linking Method Reveals a Direct Association between Claudin-1 and Tetraspanin CD9
Mol. Cell. Proteomics, November 1, 2007; 6(11): 1855 - 1867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gordon-Alonso, M. Yanez-Mo, O. Barreiro, S. Alvarez, M. A. Munoz-Fernandez, A. Valenzuela-Fernandez, and F. Sanchez-Madrid
Tetraspanins CD9 and CD81 Modulate HIV-1-Induced Membrane Fusion
J. Immunol., October 15, 2006; 177(8): 5129 - 5137.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Singethan, E. Topfstedt, S. Schubert, W. P. Duprex, B. K. Rima, and J. Schneider-Schaulies
CD9-dependent regulation of Canine distemper virus-induced cell-cell fusion segregates with the extracellular domain of the haemagglutinin
J. Gen. Virol., June 1, 2006; 87(6): 1635 - 1642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. H. Yang, O. V. Kovalenko, T. V. Kolesnikova, M. M. Andzelm, E. Rubinstein, J. L. Strominger, and M. E. Hemler
Contrasting Effects of EWI Proteins, Integrins, and Protein Palmitoylation on Cell Surface CD9 Organization
J. Biol. Chem., May 5, 2006; 281(18): 12976 - 12985.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Martin, D. M. Roth, D. A. Jans, C. W. Pouton, L. J. Partridge, P. N. Monk, and G. W. Moseley
Tetraspanins in Viral Infections: a Fundamental Role in Viral Biology?
J. Virol., September 1, 2005; 79(17): 10839 - 10851.
[Full Text] [PDF]


Home page
J. Cell Biol.Home page
Y. Takeda, I. Tachibana, K. Miyado, M. Kobayashi, T. Miyazaki, T. Funakoshi, H. Kimura, H. Yamane, Y. Saito, H. Goto, et al.
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes
J. Cell Biol., June 9, 2003; 161(5): 945 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. J. Willett, C. A. Cannon, and M. J. Hosie
Upregulation of Surface Feline CXCR4 Expression following Ectopic Expression of CCR5: Implications for Studies of the Cell Tropism of Feline Immunodeficiency Virus
J. Virol., August 12, 2002; 76(18): 9242 - 9252.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Schmid, A. Zurbriggen, U. Gassen, B. Rima, V. ter Meulen, and J. Schneider-Schaulies
Antibodies to CD9, a Tetraspan Transmembrane Protein, Inhibit Canine Distemper Virus-Induced Cell-Cell Fusion but Not Virus-Cell Fusion
J. Virol., August 15, 2000; 74(16): 7554 - 7561.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
J. Schneider-Schaulies
Cellular receptors for viruses: links to tropism and pathogenesis
J. Gen. Virol., June 1, 2000; 81(6): 1413 - 1429.
[Full Text]


Home page
J. Gen. Virol.Home page
M. A. Sommerfelt
Retrovirus receptors
J. Gen. Virol., December 1, 1999; 80(12): 3049 - 3064.
[Full Text]


Home page
J. Cell Biol.Home page
I. Tachibana and M. E. Hemler
Role of Transmembrane 4 Superfamily (TM4SF) Proteins CD9 and CD81 in Muscle Cell Fusion and Myotube Maintenance
J. Cell Biol., August 23, 1999; 146(4): 893 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. F. Egberink, E. De Clercq, A. L. W. Van Vliet, J. Balzarini, G. J. Bridger, G. Henson, M. C. Horzinek, and D. Schols
Bicyclams, Selective Antagonists of the Human Chemokine Receptor CXCR4, Potently Inhibit Feline Immunodeficiency Virus Replication
J. Virol., August 1, 1999; 73(8): 6346 - 6352.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J. Richardson, G. Pancino, R. Merat, T. Leste-Lasserre, A. Moraillon, J. Schneider-Mergener, M. Alizon, P. Sonigo, and N. Heveker
Shared Usage of the Chemokine Receptor CXCR4 by Primary and Laboratory-Adapted Strains of Feline Immunodeficiency Virus
J. Virol., May 1, 1999; 73(5): 3661 - 3671.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. S. Stipp, T. V. Kolesnikova, and M. E. Hemler
EWI-2 Is a Major CD9 and CD81 Partner and Member of a Novel Ig Protein Subfamily
J. Biol. Chem., October 26, 2001; 276(44): 40545 - 40554.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.